XML 49 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements (Tables)
6 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Financial Instruments
In accordance with the fair value hierarchy, described above, the following tables show the fair value of the Company’s financial instruments that are required to be measured at fair value as of March 31, 2021 and September 30, 2020.
Fair Value Measurements as of March 31, 2021
(Level 1)(Level 2)(Level 3)Total
(in millions)
Other Current Assets:
Foreign Currency Forward Exchange Contracts (a)$— $$— $
Other Current Liabilities:
Foreign Currency Forward Exchange Contracts (a)— (1)— (1)
Contractual Obligations (b)— — (4)(4)
Other Noncurrent Assets:
Equity Method Investment (c)— 67 — 67 
Equity Investment with Readily Determinable Fair Value (d)— 32 — 32 
Other Noncurrent Liabilities:
Contractual Obligations (b)— — (12)(12)
Interest Rate Swaps (e)— (30)— (30)
Total$— $69 $(16)$53 

Fair Value Measurements as of September 30, 2020
(Level 1)(Level 2)(Level 3)Total
(in millions)
Other Current Liabilities:
Contractual Obligations (b)$— $— $(2)$(2)
Other Noncurrent Assets:
Equity Method Investment (c)— 47 — 47 
Other Noncurrent Liabilities:
Contractual Obligations (b)— — (4)(4)
Interest Rate Swaps (e)— (38)— (38)
Total$— $$(6)$
______________________________________
(a)The fair value of foreign currency forward exchange contracts is based on dealer quotes of market forward rates and reflects the amount that the Company would receive or pay at their maturity dates for contracts involving the same currencies and maturity dates.
(b)This represents contingent consideration related to an acquisition. This is based on a probability weighted performance approach and it is adjusted to fair value on a recurring basis and any adjustments are typically included as a component of operating income in the consolidated statements of operations. This amount was mainly calculated using unobservable inputs such as future earnings performance of the acquiree and the expected timing of the payment.
(c)This represents an equity method investment acquired in fiscal 2019 whereby the Company has elected the fair value option under ASC 825, Financial Instruments (“ASC 825”). The valuation is based upon quoted prices in active markets and model-based valuation techniques to determine fair value.
(d)This represents an equity investment with a readily determinable fair value that was acquired and subsequently became publicly traded during the six months ended March 31, 2021. The Company has measured its investment to fair value in accordance with ASC 321, Investments—Equity Securities, based on quoted prices in active markets. The Company recognized an unrealized gain on this equity investment of $12 million for both the three and six months ended March 31, 2021, which was recorded as a component of other income in the consolidated statements of operations.
(e)The fair value of the interest rate swaps is based on dealer quotes of market forward rates and reflects the amount that the Company would receive or pay as of March 31, 2021 for contracts involving the same attributes and maturity dates.
Reconciliation of Net Liabilities Classified as Level 3
The following table reconciles the beginning and ending balances of net liabilities classified as Level 3:
Total
(in millions)
Balance at September 30, 2020$(6)
Additions(10)
Reductions— 
Payments— 
Balance at March 31, 2021$(16)